Sorry, you need to enable JavaScript to visit this website.

DUAVEE® (conjugated estrogens/bazedoxifene) Indications and Usage

1 INDICATIONS AND USAGE

DUAVEE is indicated in women with a uterus for:

1.1 Treatment of Moderate to Severe Vasomotor Symptoms Associated with Menopause

1.2 Prevention of Postmenopausal Osteoporosis

1.3 Important Limitations of Use

  • Use DUAVEE for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be re-evaluated periodically as clinically appropriate to determine if treatment is still necessary.
  • When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medication should be carefully considered.

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for DUAVEE®